Profile | GDS4284 / 1561206_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 869.214 | 72 |
GSM687648 | Patient 402 control | 957.536 | 73 |
GSM687653 | Patient 403 control | 1106.71 | 76 |
GSM687658 | Patient 404 control | 1149.69 | 76 |
GSM687663 | Patient 411 control | 835.834 | 71 |
GSM687668 | Patient 422 control | 938.564 | 73 |
GSM687673 | Patient 424 control | 754.351 | 69 |
GSM687678 | Patient 425 control | 1091.94 | 75 |
GSM687683 | Patient 427 control | 981.156 | 73 |
GSM687688 | Patient 428 control | 938.308 | 73 |
GSM687695 | Patient 441 control | 721.552 | 69 |
GSM687699 | Patient 443 control | 986.536 | 74 |
GSM687704 | Patient 444 control | 1178.3 | 76 |
GSM687707 | Patient 448 control | 1476.95 | 80 |
GSM687712 | Patient 449 control | 824.585 | 71 |
GSM687719 | Patient 450 control | 976.957 | 73 |
GSM687724 | Patient 451 control | 1112.37 | 76 |
GSM687728 | Patient 452 control | 1073.81 | 76 |
GSM687646 | Patient 401 treated 24h | 978.09 | 73 |
GSM687649 | Patient 402 treated 24h | 832.647 | 71 |
GSM687665 | Patient 411 treated 24h | 454.59 | 61 |
GSM687651 | Patient 402 treated 4 weeks | 802.376 | 70 |
GSM687667 | Patient 411 treated 4 weeks | 925.655 | 72 |
GSM687670 | Patient 422 treated 24h | 974.067 | 73 |
GSM687671 | Patient 422 treated 4 weeks | 837.561 | 71 |
GSM687654 | Patient 403 treated 24h | 899.674 | 73 |
GSM687675 | Patient 424 treated 24h | 721.396 | 69 |
GSM687685 | Patient 427 treated 24h | 927.115 | 73 |
GSM687656 | Patient 403 treated 4 weeks | 875.167 | 72 |
GSM687677 | Patient 424 treated 4 weeks | 896.487 | 72 |
GSM687687 | Patient 427 treated 4 weeks | 762.942 | 69 |
GSM687692 | Patient 428 treated 4h | 1295.37 | 78 |
GSM687716 | Patient 449 treated 4h | 861.202 | 72 |
GSM687722 | Patient 450 treated 4h | 1137.16 | 76 |
GSM687680 | Patient 425 treated 24h | 997.795 | 74 |
GSM687690 | Patient 428 treated 24h | 816.479 | 71 |
GSM687700 | Patient 443 treated 24h | 878.755 | 71 |
GSM687705 | Patient 444 treated 24h | 885.559 | 73 |
GSM687714 | Patient 449 treated 24h | 855.082 | 72 |
GSM687721 | Patient 450 treated 24h | 641.758 | 67 |
GSM687682 | Patient 425 treated 4 weeks | 1155.42 | 76 |
GSM687694 | Patient 428 treated 4 weeks | 1015.78 | 74 |
GSM687702 | Patient 443 treated 4 weeks | 914.731 | 72 |
GSM687718 | Patient 449 treated 4 weeks | 679.265 | 69 |
GSM687723 | Patient 450 treated 4 weeks | 1111.02 | 76 |
GSM687661 | Patient 404 treated 4h | 962 | 73 |
GSM687710 | Patient 448 treated 4h | 1408.57 | 79 |
GSM687726 | Patient 451 treated 4h | 1198.68 | 77 |
GSM687730 | Patient 452 treated 4h | 181.704 | 31 |
GSM687660 | Patient 404 treated 24h | 990.99 | 76 |
GSM687697 | Patient 441 treated 24h | 1478.26 | 81 |
GSM687709 | Patient 448 treated 24h | 1128.7 | 76 |
GSM687725 | Patient 451 treated 24h | 1489.82 | 80 |
GSM687729 | Patient 452 treated 24h | 1318.94 | 80 |
GSM687727 | Patient 451 treated 4 weeks | 1512.74 | 80 |
GSM687731 | Patient 452 treated 4 weeks | 1258.38 | 77 |